Officials Cast Doubt on a Dementia Drug, but Human Trials Continue

Officials Cast Doubt on a Dementia Drug, but Human Trials Continue

The S.E.C. alleged shortcomings in research said to support the drug, and its developer agreed to a $40 million settlement. Some experts wonder why clinical trials have not been stopped.
F.T.C. Clears Chevron’s Purchase of Hess With Board Condition

F.T.C. Clears Chevron’s Purchase of Hess With Board Condition

The Federal Trade Commission said the oil giant can acquire the smaller company as long as the chief executive of Hess does not join its board.